Adel Shahnam Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Abstracts this author is presenting:

• Evaluation of quality of life as an early surrogate of overall survival: an analysis from phase 3 immunotherapy trials — Breakfast session Best of the Best Posters - Clinical research across the spectrum
• Patterns of care post progression for NSCLC patients treated with definitive chemoradiation and durvalumab — Poster session 1
• Prognostic Nutritional Index (PNI) predicts progression free survival in patients with unresectable stage III non-small cell lung cancer treated with consolidation durvalumab — Poster session 1